Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
Closed Posted
- Opportunity number
- PAR-25-230
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Up to $250,000
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- Independent School Districts
- Higher Education Inst. (Public)
- Tribal Governments (Federally Recognized)
- County Governments
- Non-501(c)(3) Nonprofits
- 501(c)(3) Nonprofits
- Public or Indian Housing Auth.
- For Profit Organizations
- Small Businesses
- Higher Education Inst. (Private)
- City/Township Governments
- Other
- State Governments
- Special District Governments
- Tribal Organizations (Not Federally Recognized)
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
This Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) funding opportunity is administered by the National Institutes of Health (NIH), specifically the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). It supports research related to the causes, treatment, and prevention of arthritis, musculoskeletal, and skin diseases, as well as the training of basic and clinical scientists. The grant is open to a wide range of applicants, including state/local governments, tribal organizations, higher education institutions, nonprofits, and small businesses. This is a reissue of a previous opportunity that incorporates Simplified Review changes in Section V, while maintaining all other aspects of the original.
Recent federal grant awards under the Arthritis, Musculoskeletal and Skin Diseases Research program have ranged from smaller exploratory grants around $100,000 to large multi-year awards exceeding $1 million in total costs. Project durations typically span 2-5 years, and the research would be conducted at the facilities of the award recipients throughout the United States.
Synopsis
This Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) PAR, a re-issue of PAR-23-026, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplified Review changes in Section V are the only changes that have been made. All other aspects of this funding opportunity remain the same.
Files
| File | Type | Posted |
|---|---|---|
| PAR-25-230-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity